Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y013582 | RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | X023718 | OT / LL |
Caller states patient was not experiencing any symptoms at this time; Caller reported patient received both VARIVAX and PROQUAD vaccines at same office visit.; This spontaneous report was received from a healthcare professional regarding a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 03-JUN-2025, the patient was vaccinated with both Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) 0.5 mL administered subcutaneously in the left thigh (lot number reported as X023718, which has been verified as valid, expiration date reported and validated as 26-SEP-2025) (strength and vaccination scheme were not reported); and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot number reported as Y013582, which has been verified as valid, expiration date reported and validated as 03-FEB -2026) (strength, dose, route of administration, vaccination scheme, and anatomical site of injection were not reported) (Overdose). Both vaccines were administered as prophylaxis and reconstituted with sterile diluent (BAXTER STERILE DILUENT) (lot numbers and expiration dates were not reported). The reporter stated that the patient was not experiencing any symptoms at the time of report. Follow up information has been received from a supervisor on 20-JUN-2025, referring to the 12-months-old female patient. It was reported that on 03-JUN-2025, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot number reported as Y013582, expiration date reported as "02-FEB-2026" which has been verified as valid, expiration date validated as 03-FEB -2026) in the right thigh; On the same date the patient was vaccinated with the first dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot number reported as X023718, expiration date reported as "25-SEP-2025" which has been verified as valid, expiration date validated as 26-SEP -2025) in the left thigh. The patient was vaccinated with private funds at a private doctor's office/hospital. It was confirmed by the patient's mother via call that no adverse reactions occurred.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02818127-02818123 , CLIC number : , ESTAR number : , IRMS number : 500UW00000ciKzfYAE|20062025230039|1298 , Central date : 2025-06-21 , Classification : DMC, Attachment description : NSC Call , Safety case number : 2293871 , MNSC case number : 02818127 , MNSC interaction number : 02818123 , Integration log UniqueID : 500UW00000ciKzfYAE|20062025230039|1298 , Service cloud CaseID : 500UW00000ciKzfYAE
STERILE DILUENT